You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for OXYMETHOLONE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for OXYMETHOLONE

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou Trylead Chemical Technology ⤷  Get Started Free TL8003055 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 5281034 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1NQXXH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: OXYMETHOLONE

Last updated: July 28, 2025

Introduction

Oxymetholone, commonly known by its brand name Anadrol, is an anabolic steroid used medically for treating anemia and muscle wasting conditions. As a potent androgen and anabolic steroid, it carries significant demand within pharmaceutical manufacturing, research, and compounding sectors. The sourcing of high-quality, reliable bulk Active Pharmaceutical Ingredients (APIs) is paramount to ensure efficacy, safety, and regulatory compliance. This article provides a comprehensive overview of the global API sources for Oxymetholone, highlighting market dynamics, key manufacturers, sourcing considerations, and regulatory challenges.

Overview of Oxymetholone API

Oxymetholone is a synthetic anabolic steroid derived from dihydrotestosterone (DHT). Its chemical composition, characterized by the molecular formula C₁₁H₁₂O₂, renders it highly potent for promoting erythropoiesis and protein synthesis. The API's synthesis involves complex chemical processes, often requiring advanced manufacturing facilities capable of producing pharmaceutical-grade compounds in strict accordance with Good Manufacturing Practices (GMP). The API's quality directly influences downstream formulation stability, bioavailability, and patient safety.

Global Market for Oxymetholone API

The global demand for Oxymetholone API is driven primarily by its approved medical applications and off-label uses in sports and bodybuilding communities. While regulated markets emphasize compliance and quality standards, unregulated sectors often prioritize cost competitiveness. Notably, the API market is characterized by:

  • Manufacturing Hotspots: Predominant production hubs in China and India dominate the supply landscape due to their large-scale, cost-efficient pharmaceutical manufacturing capacities.
  • Regulatory Variability: U.S. FDA and EMA approval for APIs versus unregulated approval pathways influence sourcing decisions.
  • Supply Chain Complexity: The route from synthesis to procurement involves multiple intermediaries, emphasizing the importance of verified suppliers with transparent quality credentials.

Key API Manufacturers for Oxymetholone

Chinese API Manufacturers

China remains a leading source for bulk Oxymetholone API due to its extensive chemical manufacturing infrastructure. Wholesale suppliers such as Hunan Hailan Biological Technology Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., and Zhejiang Huakang Pharmaceutical Co., Ltd. have established capabilities to produce GMP-certified APIs, meeting international standards. Chinese manufacturers often offer competitive pricing with flexible batch sizes, but buyers must rigorously verify quality assurance practices.

Indian API Manufacturers

India hosts several established API producers, including Hetero Labs Ltd., Aurobindo Pharma, and Cadila Healthcare. These companies typically supply APIs certified under Indian GMP standards, with increasing compliance with international standards such as ISO and WHO guidelines. Indian manufacturers emphasize quality control and regulatory adherence, catering both to domestic and export markets.

European and North American Suppliers

While far fewer in numbers, some European and North American firms focus on high-purity, GMP-compliant Oxymetholone APIs. These suppliers often operate under strict regulatory oversight, offering APIs suitable for clinical trials and authorized pharmaceutical products. Examples include Boehringer Ingelheim and Pfizer—though their involvement in Oxymetholone synthesis is limited and primarily focused on finished pharmaceuticals rather than bulk raw materials.

Other Notable Sources

Limited suppliers in other regions—including South Korea and Southeast Asia—provide niche or secondary sources of Oxymetholone API, generally catering to specialty markets or research institutions. However, sourcing from these regions entails rigorous due diligence given the variability in regulatory standards.

Sourcing Considerations

Quality Certifications and Regulatory Compliance

  • GMP Certification: Essential for APIs destined for pharmaceutical formulation to ensure consistency, safety, and efficacy.
  • THIRD-PARTY Testing and Certification: Certificates of Analysis (CoA), purity assays (>98%), residual solvent testing, heavy metal analysis, and microbial limits are critical.
  • Regulatory Approval Status: Verify whether the API supplier's manufacturing processes comply with local and international regulatory standards.

Pricing and Supply Stability

Price volatility is influenced by raw material costs, manufacturing capacity, and geopolitical considerations. Long-term partnerships with verified suppliers can mitigate supply chain disruptions, especially given the sensitive nature of anabolic steroids.

Legal and Ethical Considerations

Due to Oxymetholone's controlled status in many jurisdictions, sourcing for non-legal or unapproved uses is subject to strict regulation. Businesses must ensure compliance with local laws regarding possession, distribution, and import-export controls.

Verification and Due Diligence

Potential buyers should employ comprehensive due diligence including site audits, supplier audits, and quality assessment programs. Engaging third-party quality assessment organizations can bolster confidence in supplier credentials.

Regulatory Landscape

Globally, the regulation of anabolic steroids like Oxymetholone varies significantly:

  • United States: Controlled substance Schedule III under the DEA; APIs are only available with proper licensing.
  • European Union: Classified as a controlled substance; import and distribution are tightly regulated.
  • India and China: Regulatory oversight exists but varies; some manufacturers operate with semi-regulatory oversight, necessitating thorough vetting.

Compliance with international standards such as ISO 9001, GMP, and certificates of authenticity reinforce regulatory adherence.

Challenges in Sourcing Oxymetholone API

  • Regulatory Restrictions: Constraints in import, export, and domestic distribution complicate procurement.
  • Quality Variability: Variations in manufacturing practices can lead to differences in API purity and efficacy.
  • Counterfeiting and Adulteration: Counterfeit APIs pose significant risks, highlighting the need for verified suppliers.
  • Supply Chain Risks: Political instability, pandemic disruptions, and trade tariffs can impair supply continuity.

Emerging Trends and Future Outlook

The rise of advanced chemical synthesis techniques and stringent quality standards are transforming the Oxymetholone API market. Investment in quality control infrastructure and adherence to international certifications are becoming industry norm. Additionally, increasing regulatory scrutiny may influence the proliferation of licensed manufacturers versus unregulated suppliers.

Key Takeaways

  • The primary sources for bulk Oxymetholone API are China and India, with emerging suppliers in other regions.
  • Regulatory compliance, GMP certification, and rigorous quality assurance are critical parameters in supplier selection.
  • Cost considerations must be balanced against quality assurance, regulatory adherence, and supply stability.
  • Due diligence, including supplier audits and verification of certifications, reduces risks associated with counterfeit or substandard APIs.
  • Evolving regulatory frameworks demand manufacturers and buyers stay abreast of legal changes to ensure lawful sourcing and distribution.

FAQs

1. Is it legal to purchase Oxymetholone API from international suppliers?
Legality depends on the jurisdiction. In many countries, Oxymetholone is a controlled substance, and importing or possessing it without proper authorization is illegal. Buyers must ensure compliance with local laws and secure relevant licenses.

2. What qualities should I look for in an Oxymetholone API supplier?
Look for GMP certification, comprehensive Certificates of Analysis, adherence to international quality standards (ISO, WHO), and verifiable references within the pharmaceutical industry.

3. How does API purity impact drug formulation?
High API purity (>98%) minimizes impurities that could cause adverse effects or stability issues, ensuring consistent therapeutic efficacy in finished pharmaceutical products.

4. Are there synthetic alternatives to Oxymetholone API?
While alternatives exist within the class of anabolic steroids, each has unique pharmacokinetics and regulatory status. Replacements or analogs should be evaluated for safety and compliance.

5. Can I source Oxymetholone API for research purposes?
Yes, but the procurement must align with local regulations governing controlled substances. Suppliers offering research-grade APIs typically provide documentation for safe handling and authorized use.

Conclusion

Securing reliable, high-quality bulk Oxymetholone API is vital for pharmaceutical manufacturers and research institutions while navigating complex regulatory landscapes and market dynamics. Robust due diligence, adherence to compliance standards, and strategic supplier partnerships underpin successful sourcing efforts, ensuring product safety, efficacy, and legal compliance in this highly regulated segment.


Sources:

[1] U.S. Drug Enforcement Administration (DEA), Controlled Substances Act.
[2] European Medicines Agency (EMA), Guidance on Pharmaceutical API Manufacturing.
[3] Global Chemical Supply Chains and Market Analysis Reports 2022.
[4] International Pharmaceutical Regulators Forum (IPRF), API Regulatory Standards.
[5] Industry Reports on Anabolic Steroids Market and API Market Trends.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.